We appreciate this amendment. A lot of these amendments are putting the cart before the horse. It would have been interesting to have these debates about resiliency and efficiencies prior to the administration going into the Paris accord. You do the research first and then you make a decision. Now what we are trying to do is say, okay, we have this Paris accord that the President has stepped away from, so now let's evaluate what impacts are happening. We did accept an amendment yesterday in this debate to look at both positive and negative aspects, which I think is a fair balance. There are going to be some areas of the country that are going to benefit; there are going to be some areas of the country that are going to be disadvantaged. So I think that is helpful in this debate. There is a lot of talk about an infrastructure bill coming up. We hope that would be something we would move in a bipartisan manner. I know that it is always going to be asked how to pay for it. I am willing to make the tough calls on how to pay for it. But in that infrastructure bill, it would be great if the resiliency of communities and these concerns that are being addressed could be wrapped up in something like that. Again, for this bill, Leader McConnell just said on the floor that they are not going to address it. Even if they did, the President wouldn't sign it. We will get to a point in time in this Congress when we will work together.…
Share & report
More from John Shimkus
The chairman of the full committee is correct. We appreciate his help and support in working through these technical corrections. We don't oppose them, and with that, I yield back the balance of my time.
We support the amendment because we think it is important to have a national risk communication strategy. We get troubled and we get confused in this debate when we are going to declare 7,866 chemicals toxic without doing the basic…
Do you want 10 new drugs, 30 new drugs on the market, 100 new drugs on the market or zero? H.R. 3 removes research and development investments, which will hinder innovation. Innovation doesn't always mean higher cost. Take hepatitis C…
This amendment is anything but simple. It is highly complex. Per- and polyfluorinated compounds, there are probably 5,000 different permutations, and my colleagues act like it is one formulation; and it is multiple. So what they want to do…





